SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid reports that the US president is considering reclassifying marijuana, which has sparked significant community discussion around potential benefits like tax relief and increased investment.  Traders are actively debating the likelihood and impact of the potential policy change, with some anticipating a major short squeeze while others express skepticism. Overall, the news has injected volatility and renewed interest in cannabis stocks.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending after earnings, with a mixed community sentiment as the stock experiences a sharp sell-off despite strong results and raised guidance, leading to speculation of manipulation and an AI bubble. Discussions revolve around the potential reasons for the decline, including profit-taking, margin concerns, and the overall market rotation out of tech. Despite the negative price action, many analysts have raised their price targets, fueling debate on whether this is a buying opportunity or a sign of further downside.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as investors discuss the potential for cannabis rescheduling, fueled by speculation around upcoming executive action and a Supreme Court review. Community members are weighing the implications of potential catalysts, with some anticipating a significant sector-wide breakout while others caution against hype-driven rallies. Discussion centers on the impact of rescheduling on US cannabis companies and strategies for trading sector momentum.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending amid discussions around immigration policy and potential impacts on the private prison sector, with some arguing about ethical concerns around profiting from incarceration. The community is also focused on ICE contracts and the company's financial outlook, specifically regarding potential gains, losses, and potential stock buybacks. GEO's stock performance and future prospects are debated, with some bullish and others expressing concerns about the company's management and the influence of political factors.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SUGP is trending as traders discuss its low float and potential for a significant breakout, drawing comparisons to other Hong Kong stocks like $SMX and $OCG. Community members highlight the possibility of a short squeeze and a golden cross setup, anticipating a run towards higher price levels. Traders are closely watching the stock's movement above the $6 and $8 levels as potential catalysts for further upward momentum.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

Argo Blockchain is trending due to discussions around its reverse stock split and London Stock Exchange delisting, with the community debating potential impacts. Some traders anticipate a rebound and short squeeze given the low float post-split, while others express skepticism about the company's financial health and potential for further dilution. Overall, the conversation reflects a mix of speculative hope and concern amidst restructuring efforts.

RYTHM, Inc. engages in the development of hardware and software solutions for indoor agriculture. The company was founded on June 6, 2016 and is headquartered in Rolling Meadows, IL.

RYTHM Inc.

RYTHM Inc. is trending amid community discussions about potential catalysts from its pipeline and high trading volume. Some traders are debating the offering's risk and watching for short covering, while others are focused on technical analysis and potential for a significant price move. Active discussions and user disputes are contributing to the stock's visibility.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending as the cannabis sector reacts to potential federal policy changes, particularly around rescheduling. Community discussions revolve around the perceived undervaluation of ACB, its international exposure, and whether it's lagging behind sector peers. Some traders speculate on short squeezes, while others caution against over-optimism, citing historical patterns of sector volatility and policy-related "pumps and dumps".

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending as investors debate its future, with some citing improving free cash flow and AI potential as reasons to buy, while others express concerns about leadership and profitability. Discussions also center around a potential buyout and the upcoming specs release. Sentiment appears mixed as the stock experiences volatility amid broader market fluctuations.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi (FRMI) is trending due to a sharp decline following news of a potential tenant terminating a significant funding agreement for its data center project. The community is discussing the impact of this lost contract on the company's business model and future prospects, with some questioning its valuation and long-term viability. Despite the negative news, some traders view the dip as an overreaction and a buying opportunity, citing the company's potential in the AI and data center space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Upgraded by Barclays

Barclays upgraded Amneal Pharmaceuticals from an "overweight" rating to a "strong-buy" rating in a report on Monday...

JPMorgan Chase & Co. Buys 240,676 Shares of Amneal Pharmaceuticals, Inc. $AMRX

JPMorgan Chase & Co. raised its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 22.0% during the second quarter, according to its most recent filing with the Securities and...

Arrowstreet Capital Limited Partnership Sells 96,228 Shares of Amneal Pharmaceuticals, Inc. $AMRX

Arrowstreet Capital Limited Partnership decreased its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 5.4% during the second quarter, according to its most recent...

Amneal Pharmaceuticals, Inc. $AMRX Stock Position Lifted by Walleye Capital LLC

Walleye Capital LLC grew its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 26.9% during the second quarter, according to its most recent Form 13F filing with the...

Amneal Pharma Receives FDA Approval For Cyclosporine Ophthalmic Emulsion 0.05%

(RTTNews) - Amneal Pharmaceuticals Inc. (AMRX) announced that the U.S. Food and Drug Administration has approved the company's cyclosporine ophthalmic emulsion 0.05%, a sterile, preservative-free...

Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares?

Key PointsWestshore Wealth initiated 1,381,910 shares in Amneal Pharmaceuticals, a position value increase of $13.83 million...

ANIP vs. AMRX: Which Niche Drugmaker Is the Better Pick?

ANI Pharmaceuticals' rare-disease momentum, led by surging Cortrophin Gel sales, sets up a stronger growth profile than its diversified rival.

Amneal Pharmaceuticals, Inc. $AMRX Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC decreased its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 8.5% in the 2nd quarter, according to the company in its most recent filing with the...

Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 12-Month High - Time to Buy?

Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 1-Year High - Still a Buy...

Why 2025 is a Dynamic and Transformative Year for Collegium

COLL's bold buybacks, board refresh and expanding ADHD push highlight a year of strategic moves and rising momentum.

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.18	--	--	N/A
Q3 '25	$0.14	$0.17	22.88%	BEAT
Q2 '25	$0.17	$0.25	42.86%	BEAT
Q1 '25	$0.15	$0.21	43.18%	BEAT
Q4 '24	$0.15	$0.12	-21.31%	MISSED

AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest AMRX News

AMRXAmneal Pharmaceuticals Inc - Ordinary Shares - Class A